Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-05-003285
Filing Date
2005-03-31
Accepted
2005-03-30 17:36:37
Documents
6
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 ADVANCED VIRAL RESEARCH CORP. g94161e10vk.htm 10-K 986291
2 CODE OF BUSINESS CONDUCT & ETHICS OF REGISTRANT g94161exv14w1.htm EX-14.1 34725
3 CERTIFICATION OF CEO PURSUANT TO SECTION 302 g94161exv31w1.htm EX-31.1 5983
4 CERTIFICATION OF CFO PURSUANT TO SECTION 302 g94161exv31w2.htm EX-31.2 5956
5 CERTIFICATION OF CEO PURSUANT TO SECTION 906 g94161exv32w1.htm EX-32.1 2945
6 CERTIFICATION OF CFO PURSUANT TO SECTION 906 g94161exv32w2.htm EX-32.2 2694
  Complete submission text file 0000950144-05-003285.txt   1040914
Mailing Address 200 CORPORATE BOULEVARD SOUTH . YONKERS NY 10107
Business Address 200 CORPORATE BOULEVARD SOUTH . YONKERS NY 10107 9143767383
ADVANCED VIRAL RESEARCH CORP (Filer) CIK: 0000786623 (see all company filings)

EIN.: 592646820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 033-02262-A | Film No.: 05715508
SIC: 2834 Pharmaceutical Preparations